A Handbook For Activist Scientists

Here is a book that belongs on the desk of every biomedical researcher in the United States: Building a Healthy America Conquering Disease and Disability Facts, Figures and Funding, edited by Terry L. Lierman. Lierman is president of Capitol Associates, Inc., a Washington, D.C.-based government relations firm specializing in health-related issues and funding. The volume, published last November, is the successor to a series of handbooks initiated by Mary Lasker, all entitled Killers and Cripple

Written byEugene Garfield
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Like its predecessors, Building a Healthy America aims to equip the public with current statistics and plain facts about many of the major diseases and disabilities we face in this nation, such as AIDS, Alzheimer’s disease, cancer, coronary heart disease, diabetes. stroke and 20 others.

Lierman gives a brief description of each, as well as up-to-date figures on the number of people afflicted, the costs in terms of medical care and lost productivity, and the amount spent on research in fiscal year 1987. Lierman also provides a summary of recent research advances, a list of organizations focusing on the disease, and a glossary of key terms. He has included numerous diagrams and charts to supplement the text. Moreover, in an introductory section called “How the Body Works,” he describes the basics of the cardiovascular, endocrine, immune and nervous systems, thereby giving context to the discussion of each disease.

Scientists will ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies